Wednesday, July 8, 2026

pharma · Plaque Psoriasis · Moderate-to-Severe Plaque Psoriasis · ORKA

Oruka Therapeutics

Oruka Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Waltham, USA HQ
78 Employees
Public company Type
ORKA · NYSE Ticker
Company details
Status
Public
HQ
Waltham, USA
Employees
78
Programs
6
Drugs
3
Patents
0
Intelligence · Clinical Trials

Oruka Therapeutics clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to Oruka Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Oruka Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Oruka Therapeutics.

  1. ORKA-001, Placebo for ORKA-001 — Phase 2

    Clinical update
  2. ORKA-001 Induction Dose — Phase 2

    Clinical update
  3. ORKA-001 — Phase 1

    Clinical update
  4. ORKA-001 — Phase 2

    Clinical update
  5. ORKA-002 — Phase 2

    Clinical update
  6. ORKA-002 — Phase 1

    Clinical update

Trial registry

7 studies